Last $0.67 USD
Change Today +0.06 / 9.84%
Volume 114.6K
ECTE On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stanley A. Nasraway M.D.

Member of Clinical Advisory Board, Echo Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Stanley A. Nasraway, MD serves as Chief of Surgical Critical Care and Director of Surgical Intensive Care Units at Tufts-New England Medical Center. Dr. Nasraway serves as an Associate Professor of Tufts Medical School. Dr. Nasraway serves as Chairman of the Medical Advisory Board at Echo Therapeutics, Inc. (formerly, Sontra Medical Corp.). Dr. Nasraway has been Member of Clinical Advisory Board at Echo Therapeutics, Inc. since August 7, 2005.

Corporate Headquarters*

8 Penn Center
Philadelphia, Pennsylvania 19103

United States

Phone: 215-717-4100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECTE:US $0.67 USD +0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ECHO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.